drugset / Trial / NCT02588547

Prevention of Spinal Induced Shivering During CS

NCT02588547

Phase 2 Completed 212 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study compares the efficacy of two different doses of intravenous (IV) granisetron on the prevention of postspinal shivering during cesarean section, in comparison with placebo.

Timeline

Start
2015-11
Primary completion
2017-05
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Granisetron Other / unclassified 0.7 mg Intravenous
Comparator Granisetron Other / unclassified 1 mg Intravenous